Real-PD Trial: Development of Clinical Prognostic Models for Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

304

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Parkinson's Disease
Interventions
OTHER

Clinical assessment

During the 13 week follow-up, trained physiotherapists will perform a standardized clinical assessment, based on the PPMI protocol (www.ppmi-info.org) for every included patient. This assessment will last for 60 minutes, and it will be done once.

DEVICE

Fox Insight self-monitoring android app and falls detector

Patients will be asked to wear a smartwatch and a pendant movement sensor, both with triaxial accelerometers, during day and night, for a period of 13 weeks. Additionally, a self-monitoring App on a Smartphone is used, where the patient reports when (s)he takes any PD medication. An additional, optional button allows the patient to report general feeling.

Trial Locations (1)

Unknown

Cohort 1, Multiple Locations

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

collaborator

Philips Electronics Nederland B.V. acting through Philips CTO organization

INDUSTRY

collaborator

Intel Corporation

INDUSTRY

lead

Radboud University Medical Center

OTHER